Mrsa kits
Ended Awarded Last action
- Contract number
- 36C25624F0064
- Awardee
-
Cepheid UEI W6HQTMWB9Q28
- Awarding agency
-
Veterans Integrated Service Network 16
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $60,833
Award facts
- Contract value 90% obligated
-
- $60,832.72 Current, with exercised options
- $67,387.97 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Sunnyvale, CA 94089, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | -$58,735 | |
| Funding Only Action | -$4,982 | |
| Funding Only Action | $58,997 | |
| Exercise an Option | $0 | |
| Original award | $65,553 |
About this award
Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, received a firm fixed-price delivery order valued at $67,387.97 from Veterans Integrated Service Network 16 (VISN 16) for MRSA kits. The contract, awarded on November 1, 2023, with an ultimate completion date of September 30, 2025, operates under the Department of Veterans Affairs' Multiple Award Schedule (MAS) contracting vehicle. This delivery order requires performance at Cepheid's Sunnyvale facility and carries no set-aside designation, reflecting the company's competitive positioning as a primary federal supplier of diagnostic solutions to the VA healthcare system.
This delivery order represents a continuation of Cepheid's established relationship with the Department of Veterans Affairs, where the company serves as a core supplier of molecular diagnostic testing capabilities across multiple VISNs. Cepheid's GeneXpert diagnostic platform and associated reagents and test kits support the VA's clinical laboratory operations and infectious disease testing requirements. The MRSA (methicillin-resistant Staphylococcus aureus) kits delivered under this order align with Cepheid's core competency in providing rapid molecular diagnostic testing for infectious diseases and contribute to infection prevention and control efforts across VA medical facilities within VISN 16.
Quick answers
Who was awarded contract 36C25624F0064?
36C25624F0064 was awarded to Cepheid by Veterans Integrated Service Network 16 (Veterans Health Administration) on November 1, 2023.
How much is contract 36C25624F0064 worth?
The government has obligated $60,833 on 36C25624F0064. Its potential value, with all options, is $67,388.
Is contract 36C25624F0064 an order under another contract?
Yes. 36C25624F0064 is a delivery order under GS07F0597T, a federal supply schedule, on Multiple Award Schedule (MAS).
Was contract 36C25624F0064 competed?
The extent of competition for 36C25624F0064 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award